Harold J. Burstein, Breast Cancer Specialist and Professor at Dana-Farber Cancer Institute and at Harvard Medical School, shared Sasha Gusev‘s, Statistical geneticist, Associate Prof at Dana-Ferber post on X, adding:
“Shocking disparities in utilization of essential cancer meds across the US. Or maybe not so shocking anymore. By the way, if you want great care, start in Massachusetts Dana-Farber.”
Quoting Sasha Gusev‘s post:
“Since people are talking about cutting-edge cancer treatments, it is good to remember that in many states patients do not receive targeted therapies that they are approved for. There’s a lot of alpha in getting healthcare in the US to look like it does in MA, HI, and NY.”
Other articles featuring Harold J. Burstein and Sasha Gusev on OncoDaily.